A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients

drug protocol number
C-12-008
drug sponsor
Alcon
drug study
Travoprost 0.004% / Timolol
drug trial site
KKESH
drug status
Completed
drug phase